NKGen Biotech Inc Share Price Today: Live Updates & Key Insights

NKGen Biotech Inc share price today is $0.19, up -62.91%. The stock opened at $0.5099 against the previous close of $0.5158, with an intraday high of $0.5099 and low of $0.1903.

NKGen Biotech Inc Share Price Chart

NKGen Biotech Inc

us-stock
To Invest in {{usstockname}}
us-stock

NKGen Biotech Inc Share Price Performance

$0.19 -0.6291(-62.91%) NKGN at 23 Mar 2026 02:28 PM Biotechnology
Lowest Today 0.1903
Highest Today 0.5099
Today’s Open 0.5099
Prev. Close 0.5158
52 Week High 4.06
52 Week Low 0.19
Day’s Range: Low 0.1903 High 0.5099
52-Week Range: Low 0.19 High 4.06
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -98.11
5 year return -98.02
10 year return -

NKGen Biotech Inc Institutional Holdings

NKGen Biotech Inc Market Status

NKGen Biotech Inc Fundamentals

Market Cap 23.18 M

PB Ratio 0.0

PE Ratio 0.0

Enterprise Value 51.86 M

Total Assets 16.48 M

Volume 8442495

NKGen Biotech Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:77000 0.1M, FY21:426000 0.4M

Annual Profit FY23:-15000 -0.0M, FY22:59000 0.1M, FY21:396000 0.4M

Annual Net worth FY23:-56296000 -56.3M, FY22:-26754000 -26.8M, FY21:-23265000 -23.3M

Quarterly Revenue Q2/2024:0 0.0M, Q1/2024:0 0.0M, Q4/2023:0 0.0M, Q3/2023:0 0.0M, Q2/2023:null 0.0M

Quarterly Profit Q2/2024:null 0.0M, Q1/2024:-326000 -0.3M, Q4/2023:-300000 -0.3M, Q3/2023:0 0.0M, Q2/2023:null 0.0M

Quarterly Net worth Q2/2024:-16088000 -16.1M, Q1/2024:-5382000 -5.4M, Q4/2023:-33606000 -33.6M, Q3/2023:-33177000 -33.2M, Q2/2023:null 0.0M

About NKGen Biotech Inc & investment objective

Company Information NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.

Organisation Biotechnology

Employees 63

Industry Biotechnology

CEO Dr. Paul Y. Song M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NKGen Biotech Inc FAQs

What is the share price of NKGen Biotech Inc today?

The current share price of NKGen Biotech Inc is $0.19.

Can I buy NKGen Biotech Inc shares in India?

Yes, Indian investors can buy NKGen Biotech Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy NKGen Biotech Inc shares in India?

You can easily invest in NKGen Biotech Inc shares from India by:

Can I buy fractional shares of NKGen Biotech Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NKGen Biotech Inc?

NKGen Biotech Inc has a market cap of $23.18 M.

In which sector does NKGen Biotech Inc belong?

NKGen Biotech Inc operates in the Biotechnology sector.

What documents are required to invest in NKGen Biotech Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of NKGen Biotech Inc?

The PE ratio of NKGen Biotech Inc is N/A and the PB ratio is N/A.